Display options
Share it on

Hosp Pharm. 2014 Nov;49(10):920-2. doi: 10.1310/hpj4910-920.

Atorvastatin: multiple sclerosis.

Hospital pharmacy

Joyce A Generali, Dennis J Cada

Affiliations

  1. Editor-in-Chief, Hospital Pharmacy , and Clinical Professor, Emeritus, Department of Pharmacy Practice, University of Kansas, School of Pharmacy , Kansas City/Lawrence, Kansas , e-mail: [email protected].
  2. Founder and Contributing Editor, The Formulary , and Editor, Off-Label Drug Facts , e-mail: [email protected].

PMID: 25477564 PMCID: PMC4252215 DOI: 10.1310/hpj4910-920

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to [email protected].

References

  1. J Neurol. 2012 Nov;259(11):2401-13 - PubMed
  2. Curr Opin Neurol. 2003 Jun;16(3):393-401 - PubMed
  3. Mult Scler. 2010 Apr;16(4):450-4 - PubMed
  4. PLoS One. 2008 Apr 09;3(4):e1928 - PubMed
  5. Neurosci Lett. 2003 Aug 28;347(3):159-62 - PubMed
  6. Cochrane Database Syst Rev. 2011 Dec 07;(12):CD008386 - PubMed
  7. Neurology. 2002 Oct 8;59(7):990-7 - PubMed
  8. Neurology. 2008 Oct 28;71(18):1390-5 - PubMed
  9. Am J Health Syst Pharm. 2012 Sep 1;69(17):1494-9 - PubMed

Publication Types